This project aims to estimate the seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia. We have already conducted 5 rounds of serological survey. According to data collected in October 2021, 83% of St. Petersburg residents have SARS-CoV-2 antibodies.
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data
This study summarises results from four consecutive serological surveys conducted between May 2020 and April 2021 at St. Petersburg, Russia and combines them with other SARS-CoV-2 surveillance data.
This study aims to estimate the seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia accounting for non-response bias.
Evaluation of the performance of SARS-CoV-2 antibody assays for a longitudinal populationbased study of COVID-19 spread in St. Petersburg, Russia
This study summarizes an evaluation of antibody tests used in a serological study of SARS-CoV-2 in Saint Petersburg, Russia. Researches validated three different antibody assays: chemiluminescent microparticle immunoassay (CMIA) Abbott Architect SARS-CoV-2 immunoglobulin G (IgG), enzyme linked immunosorbent assay (ELISA) CoronaPass total antibodies test, and ELISA SARS-CoV-2-IgG-EIA-BEST.